A critical advance in cancer study is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This crucial tumor suppressor protein is frequently inactivated in various forms of malignancies, resulting https://bookmarkpagerank.com/story22003745/mini-antibodies-reactivate-the-p53-protein-a-potential-pathway-for-tumor-treatment